Valuation: ATTANA AB

Market Cap 7.74M 810K 704K 656K 603K 1.14M 77.19M 1.16M 3.03M 38.48M 3.04M 2.97M 128M P/E 2024
-0.31x
P/E 2025 -1.11x
Enterprise Value 7.6M 794K 690K 644K 592K 1.12M 75.74M 1.14M 2.98M 37.76M 2.98M 2.92M 126M EV / Sales 2024
0.57x
EV / Sales 2025 5x
Free-Float
1.63%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer - 2025-03-31
Chief Executive Officer 56 2002-08-31
Director of Finance/CFO - -
Director TitleAgeSince
Director/Board Member 56 2012-08-05
Chairman 63 2015-09-30
Director/Board Member 62 2017-12-31
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 812K
+3.39%+1.67%-40.36%-44.55% 602M
+5.91%-22.79%+113.88% - 354M
+2.19%-1.55%-34.53%0.00% 108M
-1.89%+0.39%+7.88%+61.49% 101M
Average +1.92%-1.74%+11.72%+5.65% 291.36M
Weighted average by Cap. +3.58%-4.12%+11.22%-25.40%

Financials

2024 2025
Net sales 6.61M 692K 601K 560K 515K 972K 65.94M 989K 2.59M 32.87M 2.6M 2.54M 110M 4.01M 419K 364K 340K 312K 589K 39.96M 599K 1.57M 19.92M 1.57M 1.54M 66.49M
Net income -12.78M -1.34M -1.16M -1.08M -995K -1.88M -127M -1.91M -5M -63.51M -5.02M -4.91M -212M -10.5M -1.1M -954K -890K -818K -1.54M -105M -1.57M -4.11M -52.21M -4.12M -4.03M -174M
Net Debt 1.17M 122K 106K 99.22K 91.19K 172K 11.67M 175K 459K 5.82M 460K 450K 19.43M -145K -15.21K -13.22K -12.32K -11.33K -21.37K -1.45M -21.74K -56.96K -723K -57.12K -55.87K -2.41M
Logo ATTANA AB
Attana AB is a Sweden-based biotechnology company specializing in in vitro characterization of molecular interactions mimicking in vivo conditions. The Company develops proprietary label-free biosensors, based on the Quartz Crystal Microbalance (QCM) technology, for biochemical, crude, sera and cell-based assays. Its products and research services are used by pharmaceutical and biotechnology companies to quality control the production line of a biological pharmaceutical or gain insight into advanced dynamic features of target molecules, as well as by academic institutions within the life sciences. Attana’s biosensors are used to determine specificity, kinetics and affinity, among other binding characteristics of biomolecules and macrostructures of varying species such as cells, antibodies, proteins, viruses and bacteria.
Employees
-